Search results (143)
« Back to News
New technology helps decode the genetic changes behind disease
7 Oct, 2026
RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.
Everyday DNA damage reveals a hidden weakness in some cancers
28 Sep, 2026
Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
Professor Marella de Bruijn receives MRC Programme Award
11 Sep, 2026
Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.
Professor KJ Patel awarded Royal Society Buchanan Medal
27 Aug, 2026
Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.
Beyond cancer dependency maps: the PRECISE vision
10 Jul, 2026
Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.
MRC WIMM achieves Gold Green Impact award
3 Jul, 2026
Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.
New personalised therapy targets chronic blood cancer
2 Jul, 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
Professor Jan Rehwinkel receives funding to tackle viral threats
25 Jun, 2026
A research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses, which have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Professor KJ Patel awarded major European Research Council Advanced Grant
23 Jun, 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
Study reveals blood stem cells can ‘remember’ inflammation
27 May, 2026
Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May, 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.
New AI model predicts how cells choose their fate
12 May, 2026
Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.
Deputy Directors of the MRC Weatherall Institute of Molecular Medicine
7 May, 2026
Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.
Congratulations to our new Associate Professors
7 May, 2026
RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.
Kevin Rue-Albrecht to lead BioFAIR Pathfinder Project
22 Apr, 2026
Congratulations to Dr Kevin Rue-Albrecht, who has been selected as one of BioFAIR’s inaugural Pathfinder Projects.
Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme
15 Apr, 2026
Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.
Onima Chowdhury receives Cancer Research UK clinical trial grant
8 Apr, 2026
Congratulations to Dr Onima Chowdhury, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.
Announcing new Principal Investigator 2026
7 Apr, 2026
Following RDM’s annual call for researchers to apply for Principal Investigator (PI) status, we are delighted to announce the designation of a new PIs for 2026.
Verena Korber receives CRUK Career Development Fellowship
1 Apr, 2026
Congratulations to Dr Verena Korber, who has been awarded a Career Development Fellowship from Cancer Research UK.
DNA-damaging formaldehyde accelerates blood ageing by extinction of stem cells
23 Mar, 2026
Researchers from the University of Oxford, the German Cancer Research Center, and Hospital Saint-Louis have uncovered a surprising new way that blood stem cells are lost over time, offering fresh insight into ageing and diseases that affect blood production.